Isabelle Austin-Zimmerman

Research Interests

My PhD is focused on the potential of pharmacogenetic testing to guide the prescription of psychotropic drugs (antidepressants, antipsychotics and mood stabilisers). I am particularly interested in genetic variation in the cytochrome P450 family of enzymes, and how this contributes to differences in therapeutic response and severity of side effects experienced by patients.

I began my PhD in February 2018 and am funded by the Medical Research Council. My primary supervisor is Professor Elvira Bramon and my secondary supervisor is Dr Andrew McQuillin.